Wockhardt Q4 profit at Rs 335 cr on robust sales growth

New Delhi: Drug firm Wockhardt on Monday reported a consolidated net profit of Rs 334.76 crore for the fourth quarter ended March 31, 2013, mainly on back of robust sales.

It had posted a net loss of Rs 191.64 crore for the corresponding period previous fiscal, the company said in a filing to BSE.

Consolidated net sales of the company stood at Rs 1,485.50 crore for the quarter under consideration as against Rs 1,175.60 crore for the same period a year ago.

[caption id="attachment_819169" align="alignright" width="380"] Drug firm Wockhardt on Monday reported a consolidated net profit of Rs 334.76 crore for the fourth quarter ended March 31, 2013, mainly on back of robust sales.[/caption]

In a separate filing to BSE, the company said its board has "recommended dividend at the rate of 0.01% (Rs 0.0005 per preference share of Rs 5 each) absorbing a sum of Rs 2,98,557 on 475,659,941 non-convertible cumulative redeemable preference shares of Rs 5 each and 121,454,927 optionally convertible cumulative redeemable preference shares of Rs 5 each."

More from Business

The board recommended dividend of Rs 5 per equity share of Rs 5 each for the year 2012-2013, it added.

Consolidated net profit for the financial year ended March 31, 2013 stood at Rs 1,594.12 crore as against Rs 342.71 crore for the previous fiscal year.

Corresponding net sales of the company rose to Rs 5,609.42 crore for the fiscal year ended March 31, 2013 from Rs 4,350.50 crore for the earlier fiscal.

Shares of Wockhardt were today trading at Rs 1,274 per scrip in the afternoon trade on BSE, up 3.60% from its previous close.

PTI